Market Tracker

05/23 4:55am ET

Actavis Inc (NYSE:ACT)

130.04
Data as of May 22
 -0.16 / -0.12%
Today’s Change
67.67
Today|||52-Week Range
133.00
+51.21%
Year-to-Date

Today’s Trading

Previous close130.20
Today’s open129.75
Day’s range-- - --
Volume3,038,976
Average volume (3 months)1,574,305
Market cap$17.4B
Dividend yield--
Data as of 4:00pm ET, 05/22/2013

Growth & Valuation

Earnings growth (last year)-63.11%
Earnings growth (this year)+38.86%
Earnings growth (next 5 years)+11.15%
Revenue growth (last year)+29.02%
P/E ratioNM
Price/Sales1.83
Price/Book4.34

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...-1.04-1.31%
SHPGShire PLC+0.10+0.10%
ZTSZoetis Inc+0.51+1.54%
ALXNAlexion Pharmaceutic...-2.10-2.05%
Data as of 4:01pm ET, 05/22/2013

Financials

Next reporting dateJuly 31, 2013
EPS forecast (this quarter)$2.00
Annual revenue (last year)$5.9B
Annual profit (last year)$97.3M
Net profit margin1.65%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Paul M. Bisaro
Global Chief Financial Offi
cer
R. Todd Joyce, CPA
Corporate headquarters
Parsippany, New Jersey

Forecasts